key: cord-1017377-8qml9rrb
authors: Schulte-Schrepping, J.; Reusch, N.; Paclik, D.; Bassler, K.; Schlickeiser, S.; Zhang, B.; Krämer, B.; Krammer, T.; Brumhard, S.; Bonaguro, L.; De Domenico, E.; Wendisch, D.; Grasshoff, M.; Kapellos, T. S.; Beckstette, M.; Pecht, T.; Saglam, A.; Dietrich, O.; Mei, H. E.; Schulz, A. R.; Conrad, C.; Kunkel, D.; Vafadarnejad, E.; Xu, C.-J.; Horne, A.; Herbert, M.; Drews, A.; Thibeault, C.; Pfeiffer, M.; Hippenstiel, S.; Hocke, A.; Müller-Redetzky, H.; Heim, K.-M.; Machleidt, F.; Uhrig, A.; de Jarcy, L. B.; Jürgens, L.; Stegemann, M.; Glösenkamp, C. R.; Volk, H.-D.; Goffinet, C.; Raabe, J.; Kai,
title: Suppressive myeloid cells are a hallmark of severe COVID-19
date: 2020-06-05
journal: nan
DOI: 10.1101/2020.06.03.20119818
sha: 6d84d073a91bcb347f8bc69ed1056680529e146c
doc_id: 1017377
cord_uid: 8qml9rrb

'Severe Acute Respiratory Syndrome - Coronavirus-2' (SARS-CoV-2) infection causes Coronavirus Disease 2019 (COVID-19), a mild to moderate respiratory tract infection in the majority of patients. A subset of patients, however, progresses to severe disease and respiratory failure with acute respiratory distress syndrome (ARDS). Severe COVID-19 has been associated with increased neutrophil counts and dysregulated immune responses. The mechanisms of protective immunity in mild forms and the pathogenesis of dysregulated inflammation in severe courses of COVID-19 remain largely unclear. Here, we combined two single-cell RNA-sequencing technologies and single-cell proteomics in whole blood and peripheral blood mononuclear cells (PBMC) to determine changes in immune cell composition and activation in two independent dual-center patient cohorts (n=46 + n=54 COVID-19 samples), each with mild and severe cases of COVID-19. We observed a specific increase of HLA-DR high CD11c high inflammatory monocytes that displayed a strong interferon (IFN)-stimulated gene signature in patients with mild COVID-19, which was absent in severe disease. Instead, we found evidence of emergency myelopoiesis, marked by the occurrence of immunosuppressive pre-neutrophils and immature neutrophils and populations of dysfunctional and suppressive mature neutrophils, as well as suppressive HLA-DR low monocytes in severe COVID-19. Our study provides detailed insights into systemic immune response to SARS-CoV-2 infection and it reveals profound alterations in the peripheral myeloid cell compartment associated with severe courses of COVID-19.

Dual center cohort study to assess immunological alterations in COVID-19 patients 153

In order to gain detailed insights into the distinct immunological events in mild versus severe 154 COVID-19, we analyzed peripheral blood samples collected from independent cohorts of COVID-155 19 patients at two university medical centers in Germany. Samples from the Berlin cohort (cohort 156 1) were analyzed by mass cytometry (CyTOF) and single-cell RNA-sequencing (scRNA-seq) 157

using a droplet-based single cell platform (10x Chromium), while samples from the Bonn cohort 158 (cohort 2) were analyzed by multi-colour flow cytometry (MCFC) and scRNA-seq using a 159 microwell-based system (BD Rhapsody). We profiled a total of 8.1 million cells by their surface 160 protein markers and over 210,000 cells by scRNA-seq in 131 samples derived from a total of 33 161 COVID-19 patients and 23 controls (Fig. 1A+B , S1A, Table S1 ). 162 We delineated COVID-19-induced alterations of the major leukocyte lineages by mass cytometry 163 on whole blood samples from COVID-19 patients collected between day 6 and day 13 after 164 disease symptom onset and compared them to age-matched healthy controls. Two antibody 165 staining panels were designed to capture alterations in mononuclear cells (lymphocytes, 166 monocytes and dendritic cells, panel 1), and in the granulocyte compartment (panel 2), 167 respectively (Table S2) . High-resolution SPADE analysis was performed with 400 target nodes 168 and individual nodes were aggregated into cell subsets according to the expression of lineage-169 specific cell markers, such as CD14 for monocytes and CD15 for neutrophils (Fig. S1B) . 170 Visualization of t-distributed stochastic neighbor embedding (viSNE)-automated analysis 171 revealed a clear separation of samples from COVID-19 patients and healthy controls, with marked 172 changes of the monocyte-and the granulocyte compartment (Fig. 1C) . Comparison of healthy 173 control samples utilized for mass cytometry (HC CyTOF) to MCFC data from our recently 174 published cohorts of healthy controls (HC flow) (Kverneland et al., 2016) , demonstrated high 175 similarities in the proportions of granulocytes, lymphocytes, T cells, total monocytes and 176 CD14 lo CD16 hi 'non-classical' monocytes in whole blood samples from healthy controls, 177

irrespective of the applied methodology (Fig. 1D) . This allowed us to use the absolute numbers 178 of the published cohorts to also report differences in absolute numbers in COVID-19 samples. In 179 line with recent reports (Barnes et al., 2020; Xintian et al., 2020), we observed a marked 180 leukocytosis with increased proportions of granulocytes and neutrophils in patients with severe 181 COVID-19 (Fig. 1D) . In contrast, total lymphocyte-and T cell numbers were strongly reduced in 182 all COVID-19 patients. Furthermore, we found a significant reduction of monocytes, particularly 183 non-classical monocytes were virtually absent in COVID-19 (Fig. 1D) . These changes, increased 184 neutrophils in severe COVID-19 and loss of non-classical monocytes in both mild and severe 185 disease, were validated in cohort 2 by MCFC (Fig. S1C) . 186 187

Thus, SARS-CoV-2 infection induces lymphopenia and strong alterations within the myeloid 188 compartment, with a drastic reduction of non-classical monocytes and neutrophilia in severe 189 cases of cohort 1 with those in the corresponding cluster in cohort 2 revealed presence of the inflammatory 236 ISG signature within the monocyte compartment, although it spread across different clusters in 237 cohort 2 (cluster 9, 3, 1, Fig. 2C ). 238 239

Single-cell transcriptomics of PBMC from COVID-19 patients identified disease-severity 240 dependent cell subsets in the monocyte compartment as well as the appearance of two LDN 241

populations. 242 243 244

Mild COVID-19 is characterized by HLA-DR + CD11c + monocytes with an IFN signature 245 246

The monocyte compartment is particularly affected by COVID-19, as seen by mass cytometry 247 revealing a loss of CD14 lo CD16 hi non-classical monocytes, particularly in mild COVID-19 ( Fig.  248  1C+D) . Substantial shifts in monocyte subpopulation structure were also evident by scRNA-seq 249 depending on disease severity (Fig. 2) . To further dissect phenotypic alterations of the monocyte 250 compartment in SARS-CoV-2 infection, we applied mass cytometry using a panel of 38 antibodies 251 ( myeloid dendritic cells (mDC) and plasmacytoid dendritic cells (pDC) (Fig. 3A) . The classical 256 monocyte compartment displayed a high level of heterogeneity and separated into two main 257

subclusters. The majority of classical monocytes showed high expression of activation markers 258 CD38, CD95, and CXCR3. Classical monocyte separated into two main subclusters based on 259 high expression of CD62L and Ki67, indicative of proliferative capacity, versus high expression of 260 CD226, CD69, HLA-DR and CD11c identifying highly activated, inflammatory cells (Fig. 3A) .

Monocytes from COVID-19 patients were clearly separated from those of healthy controls by 262 viSNE analyses (Fig. 3B) , mainly based on higher CD226 and CXCR3 expression in COVID-19 263 (Fig. S3A) . Enhanced CD226 expression on activated monocytes might promote diapedesis 264 through endothelial junctions and tissue infiltration, potentially explaining the relative reduction in 265 overall monocytes in COVID-19 patients (Reymond et al., 2004) . Classical monocytes in mild 266 COVID-19 were enriched in HLA-DR hi and CD11c hi populations compared to severe disease and 267 healthy controls (Fig. S3A) . Thus, the response pattern of peripheral classical monocytes to 268 SARS-CoV-2 infection is associated with disease severity. 269 270

To investigate molecular responses of monocytes to SARS-CoV-2 infection, we extracted clusters 271 2, 5, 12 and 14 from the PBMC dataset of cohort 1 ( Fig. 2A) for further in-depth analysis. 272

Monocytes in cluster 2 particularly expressed genes found in classical monocytes, such as VCAN 273

and S100A10, while cells in cluster 14 were characterized by high expression of ZFP36L2 , and 274

were hence labeled as ZFP36L2 + monocytes and classical monocytes, respectively (Fig. 3C) .

Cluster 12 was defined as non-classical monocytes by high expression of FGR3A, encoding 276

CD16. As outlined before, the remaining cluster 5 (inflammatory monocytes) was characterized 277 by an ISG program, which was further corroborated by gene ontology enrichment analysis 278 (GOEA), assigning this cluster to 'type I interferon signaling pathway' (Fig. 3D ). In addition, 279 9 inflammatory (cluster 5) and non-classical monocytes (cluster 12) were also enriched for 'MHC  280  class II protein complex' (MHCII), which is concordant with the high expression of HLA-DRA and  281 HLA-DRB1 in these cells (Fig. 3C, S3B) . Expression of CD14 indicated that the ISG + cells 282 represent a population of classical monocytes (Fig. S3B) . Investigation of PBMC revealed that 283 the number of these inflammatory monocytes differed between patients with mild and severe 284 disease courses (Fig. 2E) . We next investigated this shift in greater detail in cohort 2. The 285 dimensionality reduction and re-clustering of the monocyte space revealed high transcriptional 286 heterogeneity within the monocyte compartment (Fig. 3E, S3D) . We identified three classical 287 monocyte clusters (cluster 0, 2, and 6), which showed high ISG expression (Fig. S3C+E) . 288 Interestingly, only cluster 2 cells co-expressed high levels of MHCII molecules (Fig. S3C ) and 289

were thereby identified as counterparts of the inflammatory monocyte cluster in cohort 1 (Fig.  290  3C) . In contrast, the remaining two ISG + clusters exhibited low levels of HLA-DRA and HLA-DRB1 291 expression (Fig. S3D) , and cluster 6 was additionally characterized by platelet-associated genes 292 (TUBB1, PPBP, and PF4) (Fig. S3E) , indicating that these cells represent platelet-interacting 293 inflammatory monocytes. Intriguingly, a proportion of cluster 0 monocytes expressed pre-294 maturation markers like MPO and PLAC8 and IL1R2, which were recently linked to an immature 295 monocyte population found in sepsis patients (Reyes et al., 2020) (Fig. S3F) . Indeed, the gene 296 signatures derived from these sepsis-associated monocytes were specifically enriched in clusters 297 0 and 6 ( Fig. S3G) . Low HLA-DR expression and monocyte immaturity result in reduced 298 responsiveness to microbial stimuli (Veglia et al., 2018) , which is why cluster 0 cells are referred 299

to as suppressive monocytes. To understand how the identified cell populations in the patients 300 change over time, we next investigated the time-dependent cluster occupancies per patient in 301 cohort 2 (Fig. 3F) . This analysis clearly showed that the ISG + inflammatory clusters appeared in 302 the early phase of the disease and gradually decreased over time. In addition, the inflammatory 303 cluster 2 was associated with patients exhibiting a mild course of the disease, whereas the 304 suppressive cluster 0 and platelet-activated monocyte cluster 6 were associated with severe 305 disease. The gradual decrease of the ISG + clusters was also evident in cohort 1, which showed 306 a clear time-dependent decrease of IFI6 and ISG15 (Fig. S3H) . 307 308

Taken together, we observed dynamic changes of the monocyte compartment in SARS-CoV-2-309 infected patients, associated with disease severity and time after onset of disease. 310 311 312

Low-density neutrophils emerge in severe COVID-19 patients indicative of emergency  313  myelopoiesis  314  315 Surprisingly, PBMC preparations in both cohorts contained two distinct clusters ( Fig. 2A , clusters 316 9, 13; Fig. 2D , clusters 13, 18) of LDN, specifically in patients with severe disease. Since LDN in 317 cohort 1 were more frequent than in cohort 2, we focused our in-depth analysis on cohort 1 data. 318 We subsampled all LDN (Fig. 4A ) and re-clustered the cells which gave rise to 8 transcriptionally 319 distinct clusters within the LDN compartment of PBMC (Fig. 4A+B) . We first analyzed previously 320 described markers for pre-neutrophils, immature and mature neutrophils (Ng et clusters 3 and 6 as CD11b(ITGAM) + CD101 + immature neutrophils and the remaining clusters as 323 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint mature neutrophils (Fig. S4A) . The identification of pre-neutrophils and immature neutrophils was  324  further supported by signature enrichment of neutrophil progenitors derived from previous single-325 cell data (Fig. 4C) cycle gene analysis further  326  corroborated cluster 4 being pre-neutrophils with the highest proportion of cells per cluster  327 showing a proliferative signature (Fig. S4B) . Clusters 0,1, 2 and 5 (originally from cluster 9 in Fig.  328 2A) were characterized by expression of the mature neutrophil markers FCGR3A (CD16) and 329 MME (CD10) (Fig. S4A) . 330 331

Visualizing the most differentially expressed genes for each cluster revealed extensive phenotypic 332 heterogeneity within the LDN compartment (Fig. 4B) including CD24, Olfactomedin (OLFM4), Lipocalin 2 (LCN2), Bactericidal/permeability-increasing 350 protein (BPI), previously associated with poor outcome in sepsis, were highly expressed in pre-351 and immature neutrophils (Kangelaris et al., 2015) . We also observed a very strong expression 352 of the alarmins S100A8 and S100A9, which is not restricted to the pre-and immature state ( Fig.  353 4D). Other members of the S100 gene family (e.g. S100A4, S100A12) are also strongly induced 354 in different neutrophil clusters. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint Persistent increase in activated and immunosuppressive neutrophils in severe COVID-19 368 369

To further dissect the profound alterations within the neutrophil compartment, we applied mass 370 cytometry to whole blood samples from cohort 1 and age-and gender-matched healthy controls. 371 We specifically designed the antibody panel 2 to not only identify neutrophils but also discriminate 372 between maturation stages and reveal phenotypical signs of activation, immunosuppressive 373

properties or dysfunction. Unsupervised clustering analysis of all neutrophils acquired from 374 healthy control and COVID-19 samples identified 7 major subsets (Fig. 5A) . Whereas neutrophils 375 belonging to cell subsets 2, 5 and 7 appeared quiescent, with low expression of activation markers 376 like CD64, neutrophil subsets 1 and 6 appeared to be dominated by highly activated, CD64 + , 377

Siglec 8 + , RANK + and RANKL + as well as Ki67 + proliferating cells. Cells within subset 3 adopted 378 an intermediate phenotype. Neutrophils from COVID-19 patients clearly separated from those of 379 healthy controls, and neutrophils in patients with severe COVID-19 were distinct from those of 380 patients with mild disease (Fig. 5B) . on neutrophils of severe COVID-19 patients. In addition, neutrophils of severe COVID-19 patients 390

adopted an aged phenotype with elevated CD45 expression (Fig. 5B) .

Thus, SARS-CoV-2 infection induces major alterations in the neutrophil compartment. While 393 neutrophils in patients with mild COVID-19 display an activated phenotype, additional markers of 394 immunosuppression or dysfunction are upregulated in patients with severe disease. 395 396

The differences in the functional states of neutrophils in mild and severe COVID-19 in the snap-397 shot analysis, prompted us to perform a longitudinal analysis. We analyzed samples according to 398 collection either within the first 10 days (early) or during the second and third week (late) after 399 onset of disease symptoms. The proportional increase in total granulocytes and CD34 + neutrophil 400 subset in severe COVID-19 was only detected during the early phase of the disease (Fig. 5D+E) . 401 However, the additionally observed alterations in the neutrophil compartment such as loss of 402 CD62L expression accompanied by increase of CD123 and PD-L1 positive populations as signs 403 of dysfunctionality and immunosuppressive properties were persistent in severe COVID-19 404 patients (Fig. 5E) . 405 406

Next, we analyzed whether similar to the evolution on the transcriptional level, we can also capture 407 time-dependent changes of the monocyte compartment on the protein level. The proportion of 408 non-classical monocytes started to recover in mild patients during the later stages of the disease 409 (Fig. 5D) . This was accompanied by reduced CD11c and CXCR3 expression in classical 410 monocytes (Fig. 5F ) and relates very well to the described longitudinal changes of the HLA-DR 411 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint & ISG + monocyte cluster (Fig. 3F, S3H) . In contrast, although classical monocytes of severe 412 patients never showed high CD11c expression, they maintained high levels of CXCR3 expression 413 even in late stages of the disease, indicating prolonged activation (Fig. 5F) batch correction, revealed the major cell type distribution, including the granulocyte compartment 429 (Fig. 6A, S6A ). Cell type distribution as identified by scRNA-seq ( Fig. S6B ) strongly correlated 430

with the MCFC data of the same samples (Fig. S6C) . We noticed abnormal transcriptional 431 activation in six samples, which was caused by protracted cold treatment (4°C) prior to single-cell 432 sampling, as recently described for PBMC (Massoni-Badosa et al., 2020). These samples were 433 therefore excluded from further analysis. The remaining 30,019 neutrophils were subsampled and 434 revealed a structure of 11 clusters ( Fig. 6B-C) . Using marker-and data-driven approaches as 435 applied to LDN (Fig. 4D, S4A) , we identified CD15(FUT4) + CD63 + CD66b + CD101 + CD10pre-436 neutrophils, CD11b(ITGAM) + CD101 + CD10immature neutrophils along with 9 mature neutrophil 437 clusters ( Fig. 6B -D, S6D-E). Heterogeneous expression of various markers involved in neutrophil 438 function including SELL (L-selectin, CD62L), CXCR2, FCGR2 (CD32), and CD10 as a marker for 439 mature neutrophils, pointed towards distinct functionalities within the neutrophil compartment 440 (Fig. 6C, 6H , S6E). The phenotypic diversity was further corroborated, when we assessed the 441 expression of markers previously identified by CyTOF to be differentially regulated in patients with 442

severe COVID-19 (Fig. 5) . For example, we found elevated expression of CD274 (PD-L1) and 443

CD64 in neutrophil clusters identified specifically in patients with severe COVID-19 (Fig. 6E, S6F ). 444

Out of the 11 neutrophil clusters identified in whole blood in cohort 2, 10 clusters could also be 445 mapped to fresh PBMC samples in cohort 1 (Fig. S6D) , indicating that scRNA-seq of fresh PBMC 446 -in COVID-19 patients -reveals relevant parts of the neutrophil compartment. When we analyzed 447 PBMC samples of cohort 2, these clusters could be identified in fresh samples, but were lost upon 448 freezing (Fig. S6A) . Importantly, the analysis corroborated the transcriptional phenotype of pre-449 neutrophils and immature neutrophils (cluster 8+9) in cohort 2 ( Fig. 6B -D, S6D-E). 450

Heatmap and UMAP visualization of the cell type distribution identified pre-neutrophils and 451

immature neutrophils in severe COVID-19, at late time points (Fig. 6F-G) . Furthermore, clusters 452 2 and 0 were associated with severe COVID-19, while clusters 5 and 10 were found in mild 453 COVID-19 ( Fig. 6F-G) . IFN-signatures were detected in neutrophils from mild and severe COVID-454

19 patients and even in some of the clusters derived from controls (Fig. S6G) . However, 455 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. COVID-19 expressed FCGR1A, ICAM1 and ZC3H12A (Fig. 6H) , indicative of their suppressive 461 nature. As indicated by the clustering in the UMAP (Fig. 6B+G) , pseudotime analysis strongly 462

suggested that cells in cluster 2 preceded those in cluster 0, and particularly CD274 (PD-1L) was 463 among the genes that further enriched in cluster 0 compared to cluster 2, indicating a progression 464 towards a suppressive phenotype in late stage disease (Fig. S6H+I) . Predictions of transcription 465 factor (TF)-based regulation of the cluster-specific gene signatures revealed a strict separation of 466 mature neutrophils from pre-neutrophils and immature neutrophils (Fig. S6J ), but showed a 467 surprisingly high overlap between clusters 5 (mild), 2 (severe early), and 0 (severe late) in STAT-468

and IRF-family member TFs (Fig. 6I) . However, there was a striking loss of important TF hubs in 469 cluster 0, found in late stage severe COVID-19 ( Fig. 6I) .

Collectively, the neutrophil compartment in peripheral blood of COVID-19 patients is 472 characterized by the appearance of LDN, ARG1 + MPO + BPI + pre-neutrophils and CD10 + 473 S100A8/A9 + immature neutrophils, reminiscent of emergency myelopoiesis, as well as 474 CD274 + (PD-L1 + ) suppressive mature neutrophils. All neutrophil subsets emerging in severe 475 COVID-19 express an armamentarium of genes associated with suppressive functions as they 476

have been described for sepsis or ARDS, indicating that a dysregulated myeloid cell compartment 477

contributes to severe COVID-19. 478 479 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. patients, which was particularly prominent in mild cases and less pronounced in severe disease 516 (Fig. 1D) . This is in line with previous reports, and it has also been observed in other severe viral 517

infections ( which were absent in severe cases (Fig. 3) . In contrast, we identified immature suppressive 520 monocytes with low expression of HLA-DR in patients with severe disease. Low HLA-DR 521 expression on monocytes has been previously associated with an increased risk to develop 522 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. Here we detected pre-neutrophils and immature neutrophils within PBMC, indicating their reduced 535 cellular density, specifically in severe COVID-19 (Fig. 4) . COVID-19, none of these transcriptional programs was observed. Despite the fact that SARS-555

CoV2 neg controls exhibited a range of comorbidities (e.g. COPD, type diabetes II), we did not 556 observe this massive expansion of suppressive neutrophils in these chronic inflammatory 557

conditions. The pathophysiological consequences of this suppressive signature in severe COVID-558

19 are unclear at this stage, but it is highly likely that they contribute to immunoparalysis in 559 critically ill patients, potentially leading to insufficient host defense, disbalanced inflammation and 560

increased susceptibility to superinfections. 561 562

Collectively, our data link a striking appearance of immature and suppressive cells, in both the 563 monocyte and neutrophil compartment, to disease severity in COVID-19. Consequently, for the 564 development of better treatments and prevention of severe COVID-19, we may benefit from 565 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint achievements in other fields such as cancer, which have successfully applied therapies targeting 566 suppressive myeloid cells. 567

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. COVID-19 patients ( Figure 1A+B , Table S1 ). All COVID-19 patients tested positive for SARS-577

CoV-2 RNA in nasopharyngeal swabs. 578

This study was approved by the Institutional Review board of the University Hospital Bonn (073/19 580 and 134/20). After providing written informed consent, 12 control donors (Table S1 ) and 14 581

COVID-19 patients ( Figure 1A+B , Table S1 ) were included in the study. In patients who were 582 not able to consent at the time of study enrollment, consent was obtained after recovery. COVID-583

19 patients who tested positive for SARS-CoV-2 RNA in nasopharyngeal swabs were recruited 584 at the Medical Clinic I of the University Hospital Bonn between March 30 and May 17, 2020. 585 586

Cohort 1 / Berlin cohort 588 589 PBMC were isolated from heparinized whole blood by density centrifugation over Pancoll (density: 590

1.077g/ml; PAN-Biotech™). If the pellet was still slightly red, remaining CD235ab + cells 591

(Erythrocytes) were depleted by Negative Selection (MagniSort™ Thermo Fisher). Subsequently 592 the PBMC were prepared for 3'scRNA-seq (10xGenomics) or cryopreserved and analyzed later. 593 594

In the Bonn cohort, scRNA-seq was performed on fresh whole blood, fresh PBMC and frozen 596 PBMC. Briefly, PBMC were isolated from EDTA-treated or heparinized peripheral blood by density 597 centrifugation over Pancoll or Ficoll-Paque density centrifugation (density: 1.077g/ml). Cells were 598 then washed with DPBS, directly prepared for scRNA-seq (BD Rhapsody) or cryopreserved in 599 RPMI-1640 with 40% FBS and 10% DMSO. Whole blood was prepared by treatment of 1 ml 600 peripheral blood with 10 ml of RBC lysis buffer (Biolegend). After one wash in DPBS cells were 601 directly processed for scRNA-seq (BD Rhapsody) or MCFC. Frozen PCMC were recovered by 602 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint rapidly thawing frozen cell suspensions in a 37° C water bath followed by immediate dilution in 603

pre-warmed RPMI-1640+10% FBS (Gibco) and centrifugation at 300g for 5 min. After 604 centrifugation, the cells were resuspended in RPMI-1640+10% FBS and processed for scRNA-605 seq. Antibody cocktails were cryopreserved as described before . 606

Antibodies used for mass cytometry 607 608

All anti-human antibodies pre-conjugated to metal isotopes were obtained from Fluidigm 609

Corporation (San Francisco, US). All remaining antibodies were obtained from the indicated 610 companies as purified antibodies and in-house conjugation was done using the MaxPar X8 611 labeling kit (Fluidigm . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. Biolegend, including primer sequences and reagent specifications. Biometra Trio Thermal Cycler 685 was used for amplification and incubation steps (Analytik Jena). Libraries were quantified by 686

Qubit TM 2.0 Fluorometer (ThermoFisher) and quality was checked using 2100 Bioanalyzer with 687 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. Data pre-processing of 10x Genomics Chromium scRNA-seq data 714 715

CellRanger v3.1.0 (10x Genomics) was used to process scRNA-seq. To generate a digital gene 716 expression (DGE) matrix for each sample, we mapped their reads to a combined reference of 717

GRCh38 genome and SARS-CoV-2 genome, and recorded the number of UMIs for each gene in 718 each cell. 719 720

Data pre-processing of BD Rhapsody scRNA-seq data 721 722

After demultiplexing of bcl files using Bcl2fastq2 V2.20 from Illumina and quality control, paired-723 end scRNA-seq reads were filtered for valid cell barcodes using the barcode whitelist provided by 724 BD. Cutadapt 1.16 was then used to trim NexteraPE-PE adapter sequences where needed and 725

to filter reads for a PHRED score of 20 or above. Then, STAR 2.6.1b was used for alignment 726 against the Gencode v33 (GRCh38.p13) reference genome. dropseq-tools 2.0.0 were used to 727 quantify gene expression and collapse to UMI count data. For hashtag-oligo based demultiplexing 728 of single-cell transcriptomes and subsequent assignment of cell barcodes to their sample of origin 729 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint the respective multiplexing tag sequences were added to the reference genome and quantified 730 as well. 731 732

ScRNA-seq data analysis of 10x Chromium data of cohort 1 733 734

ScRNA-seq UMI count matrices were imported to R 3.6.2 and gene expression data analysis was 735 performed using the R/Seurat package 3.1.4 (Butler et al., 2018; Hafemeister and Satija, 2019). 736

Demultiplexing of cells was performed using the HTODemux function implemented in Seurat. 737 738

Data quality control. 739 We excluded the cells based on the following criteria: more than 5% mitochondrial reads, less 740 than 200 expressed genes or more than 6000 expressed genes. We further excluded genes that 741

were expressed in less than five cells. Cluster annotation. 770 Clusters were annotated based on a double-checking strategy: 1) by comparing cluster marker 771 genes with public sources, and 2) by directly visualizing the expression pattern of CyTOF marker 772 genes. 773 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. ScRNA-seq data analysis of Rhapsody data of cohort 2 798

ScRNA-seq UMI count matrices were imported to R 3.6.2 and gene expression data analysis was 800 performed using the R/Seurat package 3.1.2 (Butler et al., 2018) . Demultiplexing of cells was 801 performed using the HTODemux function implemented in Seurat. After identification of singlets, 802 cells with more than 25% mitochondrial reads, less than 250 expressed genes or more than 5000 803 expressed genes were excluded from the analysis and only those genes present in more than 5 804 cells were considered for downstream analysis. The following normalization, scaling and 805 dimensionality reduction steps were performed independently for each of the data subsets used 806

for the different analyses as indicated respectively. In general, gene expression values were 807 normalized by total UMI counts per cell, multiplied by 10,000 (TP10K) and then log transformed 808 by log10(TP10k+1). Subsequently, the data was scaled, centered and regressed against the 809 number of detected genes per cell to correct for heterogeneity associated with differences in 810 sequencing depth. For dimensionality reduction, PCA was performed on the top 2000 variable 811 genes identified using the vst method implemented in Seurat. Subsequently, UMAP was used for 812

two-dimensional representation of the data structure. No batch effect removal or data integration 813 analysis was performed on the BD Rhapsody data. Cell type annotation was based on the 814 respective clustering results combined with data-driven cell type classification algorithms based 815 on reference transcriptomes data (Aran et al., 2019) and expression of known marker genes. 816 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint

ScRNA-seq count data of 162,797 cells derived from fresh and frozen PBMC samples purified by 819 density gradient centrifugation and whole blood after erythrocyte lysis of cohort 2 (Bonn, BD 820

Rhapsody) were combined, normalized and scaled as described above. After variable gene 821 selection and PCA, UMAP was performed based on the first 25 principal components (PCs 

ScRNA-seq count data of 93,297 cells derived from fresh and frozen PBMC samples of cohort 2 829 (Bonn, BD Rhapsody) purified by density gradient centrifugation were normalized and scaled as 830 described above. After variable gene selection and PCA, UMAP was performed and the cells 831

were clustered using the Louvain algorithm based on the first 15 PCs and a resolution of 0.5. 832

Cluster identities were determined by reference-based cell classification and inference of cluster-833 specific marker genes using the Wilcoxon rank sum test using the following cutoffs: genes have 834 to be expressed in more than 20% of the cells of the respective cluster, exceed a logarithmic 835 fold change cutoff to at least 0.25, and exhibited a difference of > 10% in the detection between 836 two clusters. 837

To compare shifts in the monocyte and neutrophil populations in the PBMC compartment of 840 COVID-19 patients, the percentages of the cellular subsets -as identified by clustering and cluster 841 annotation explained above for the two independent scRNA-seq data sets (cohort 1 and cohort 842

2) -of the total number of PBMC in each data set were quantified per sample and visualized 843 together in box plots. Statistical significance was inferred using t-test. 844

The monocyte space was investigated by subsetting the PBMC dataset to those clusters identified 846 as monocytes (cluster 1, 3 ,5 ,9, and 12) and repeating the variable gene selection (top 2000  847 variable genes), regression for the number of UMIs and scaling as described above. The 848 dimensionality of the data was then reduced to 8 PCs, which served as input for the UMAP 849

calculation. The SNN-graph based Louvain clustering of the monocytes was performed using a 850 resolution of 0.48. Marker genes per cluster were calculated using the Wilcoxon rank sum test 851 using the following cutoffs: genes have to be expressed in > 20% of the cells, exceed a 852 logarithmic fold change cutoff to at least 0.25, and exhibited a difference of > 10% in the detection 853 between two clusters. 854 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint

For each patient and time point of sample collection, the proportional occupancy of the monocyte 856 clusters was calculated, and the relative proportions were subsequently visualized as a function 857 of time. 858

ScRNA-seq count data derived from fresh PBMC samples purified by density gradient 860 centrifugation and whole blood after erythrocyte lysis of cohort 2 (BD Rhapsody) were normalized, 861 scaled, and regressed for the number of UMI per cell as described above. After PCA based on 862 the top 2000 variable genes, UMAP was performed using the first 15 PCs. Cell clusters were 863 determined using Louvain clustering implemented in Seurat based on the first 15 principle 864 components and a resolution of 0.5. Cluster identities were assigned as detailed above using 865 reference-based classification and marker gene expression. Subsequently, the dataset was 866 subsetted for clusters identified as neutrophils and pre-neutrophils, and re-scaled and regressed. 867

After PCA on the top 2000 variable genes, UMAP was performed on the first 15 PCs. Clustering 868 was performed as described above on the top 15 PCs using a resolution of 0.5. Clusters featuring 869 high counts in hemoglobin genes and expression of the eosinophil specific marker gene CLC 870

were excluded from subsequent analyses. After filtering and rescaling of the neutrophil 871 compartment a division of the cells according to experimental batches was observed in the 872 two-dimensional UMAP representation. Comparing experimental procedures of different 873 experiments pointed to short-term storage of whole blood on ice for a single experimental 874 batch as a technical influence potentially explaining the transcriptional differences. Therefore, 875 cells from the respective experiment were excluded, reducing the number of samples to a 876 total of 15 (30,019 cells, 10 controls, 5 COVID-19 patients) to prevent any technical bias from 877 skewing the analysis. After exclusion, the remaining data were processed as described above 878 and clustered using Louvain clustering based on the first 15 PCs with a resolution of 0.7 was 879 performed. 880

Differentially expressed genes between clusters were defined using a Wilcoxon rank sum test for 881 differential gene expression implemented in Seurat. Genes had to be expressed in >10% of the 882 cells of a cluster, exceed a logarithmic threshold >0.1 and to have >10% difference in the minimum 883 detection between two clusters. 884

After cell type classification of the combined scRNA-seq data set of fresh PBMC and whole blood 887 samples of cohort 2 described above, 69.500 cells derived from whole blood samples after 888 erythrocyte lysis were subsetted. Percentages of cell subsets in those whole blood samples of 889 the total number of cells were quantified per sample and visualized r in box plots separated by 890 disease stage and group. 891

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. for predicted TFs with a normalized enrichment score > 4.0. Next, we filtered for TFs, which 921 exceeded a cumulative normalized expression cutoff of 50 in the respective neutrophil cluster. 922

Subsequently, we selected transcription factors of known relevance in the context of neutrophil 923 biology and constructed a network linking target genes among the cluster-specifically expressed 924 marker genes and their predicted and expressed regulators for visualization in Cytoscape. 925

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint Cytobank.org was used for de-barcoding of individual samples and manually gating of cell events 927 to remove doublets, normalization beads and dead cells (Kotecha et al., 2010) . For semi-928 automated gating of populations of interest, high-resolution SPADE clustering was conducted on 929 all indicated markers (supplementary table 2) with 400 target nodes. Individual SPADE nodes  930 were then aggregated and annotated to cell subsets (bubbles) according to the expression of 931 lineage-specific differentiation markers. 932

To generate tSNE maps viSNE analysis was performed using the indicated markers 933 (supplementary table 2 ). Embedding parameters were set to at least 1000 iterations per 100.000 934 analyzed cells, perplexity of 30 and theta of 0.5. For statistical analysis of cell population 935 abundances, we fitted a generalized linear mixed-effects model (GLMM) for each population using 936 the lme4 package as previously described by Nowicka et. al (Robinson et al., 2017) . 937

Flow cytometry data analysis was performed with FlowJo V10.6.1. Relative cell percentage or 939 mean fluorescence intensity (MFI) was used for visualization and statistical analysis. Cell type 940 was defined as granulocytes (CD45 + , CD66b + ), non-classical monocytes (CD45 + , CD66b -, CD19 -941 , CD3 -, CD56 -, CD14 dim , CD16 + ). 942

In general, the R packages Seurat and the ggplot2 package (version 3.1.0, Wickham, 2016) were 944 used to generate figures. For visualization of mass cytometry data, cluster minimum-spanning 945 trees were rendered using Cytobank, the ComplexHeatmap package was used to display subset 946 phenotypes and GraphPad Prism to generate boxplots of quantitative data. 947

Further information and requests for resources and reagents should be directed to the Lead 949

Contact, Joachim L. Schultze 950

Data are deposited at the European Genome-phenome Archive (EGA) under access number 952 EGAS00001004450, which is hosted by the EBI and the CRG. 953 954 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint 1326 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint 1340 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint 1365 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2020. determined for the clusters depicted in the UMAP in Figure 2C . 1373 1374 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint 1375 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint IDs are shown on the right. 1399 1400 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint 1401 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. A, Box plots summarizing differences in CD226, HLA-DRhigh, CD11c and CXCR3 expression 1404 within classical monocytes measured by mass cytometry in whole blood samples from cohort 1 1405 distinguishing between healthy controls (n=7), COVID-19 patients with mild (n=5) or 1406 severe/critical disease (n=6) course. *p<0.05, **p>0.01 1407 B, Violin plots representing expression of selected genes in monocyte clusters of cohort 1. 1408

Coloring according to cluster color in Figure 2 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. clusters as identified in the UMAP in Figure 4A . 1442 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 5, 2020. . https://doi.org/10.1101/2020.06.03.20119818 doi: medRxiv preprint

Transcriptome meta-analysis deciphers a 959 dysregulation in immune response-associated gene signatures during sepsis

SCENIC: Single-cell regulatory 963 network inference and clustering

Olfactomedin-4 Is 965 a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock

Advances in understanding 969 large-scale responses of the water cycle to climate change

Destiny: 971 Diffusion maps for large-scale single-cell data in R

Reference-based analysis of lung single-cell sequencing reveals 974 a transitional profibrotic macrophage

Gene ontology: Tool for the unification of biology

Targeting potential drivers 980 of COVID-19: Neutrophil extracellular traps

Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway. PLoS 983 Pathog

Presence of SARS-CoV-2 reactive T cells in COVID-986 19 patients and healthy donors

The possible utility of steroids in the prevention of relapses of 989 crohn's disease in remission: A preliminary study

L-arginine metabolism 991 in myeloid cells controls T-lymphocyte functions

Integrating single-cell 993 transcriptomic data across different conditions, technologies, and species

The Gene Ontology Resource: 20 years and still 997 GOing strong

Deciphering myeloid-derived suppressor cells: isolation 1000 and markers in humans, mice and non-human primates

Clinical and immunologic features in severe and moderate Coronavirus Disease

Neutrophils with myeloid derived 1007 suppressor function deplete arginine and constrain T cell function in septic shock patients

FAVORABLE 1011 ANAKINRA RESPONSES IN SEVERE COVID-19 PATIENTS WITH SECONDARY 1012 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Coast-to-Coast Spread of SARS-CoV-2 1015 during the Early Epidemic in the United States

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell 1019 Host Microbe

Targets of T cell responses to SARS-1022

CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. 1025

Comorbidity and its impact on 1590 patients with Covid-19 in 1028 China: A Nationwide Analysis

Impaired type I interferon activity and 1031 exacerbated inflammatory responses in severe Covid-19 patients

Normalization and variance stabilization of single-cell 1034 RNA-seq data using regularized negative binomial regression

Effect of granulocyte colony-stimulating factor treatment on ex vivo blood 1037 cytokine response in human volunteers

Neutrophil heterogeneity and its role in infectious 1040 complications after severe trauma

SARS-CoV-2 Cell Entry Depends on ACE2 1043 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Stroke-induced immunodepression 1046 and dysphagia independently predict stroke-associated pneumonia -The PREDICT study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 1050 Lancet

Should we stimulate or suppress immune responses in COVID-19? 1053 Cytokine and anti-cytokine interventions

Human suppressive neutrophils CD16 bright /CD62L dim exhibit decreased adhesion

Toward understanding the origin and evolution of cellular organisms

Increased expression of neutrophil-related genes in 1061 patients with early sepsis-induced ARDS

Incidence 1065 of thrombotic complications in critically ill ICU patients with COVID-19

Web-based analysis and publication of flow 1067 cytometry experiments

Studying the 1070 pathophysiology of coronavirus disease 2019 -a protocol for the Berlin prospective COVID-19 1071 patient cohort (Pa-COVID-19)

Age and gender leucocytes variances 1074 and references values generated using the standardized ONE-Study protocol

PAD4 1077 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin 1078 unfolding to form neutrophil extracellular trap-like structures

Angiotensin-converting enzyme 2 is a 1081 functional receptor for the SARS coronavirus

Arginine deficiency is involved in thrombocytopenia and immunosuppression in 1084 severe fever with thrombocytopenia syndrome

The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-1087 cell RNA sequencing

The Molecular Signatures Database Hallmark Gene Set Collection

Dysregulated myelopoiesis and 1091 hematopoietic function following acute physiologic insult

Antibody responses to SARS-CoV-2 in patients with COVID-19

Ebola Virus Disease Is 1097 Characterized by Poor Activation and Reduced Levels of Circulating CD16+ Monocytes

Sampling time-1101 dependent artifacts in single-cell genomics studies

The innate immune system: fighting on the front lines or 1103 fanning the flames of COVID-19?

Barcoding of Live 1105 Human Peripheral Blood Mononuclear Cells for Multiplexed Mass Cytometry

Platinum-conjugated antibodies for 1108 application in mass cytometry

The CD14+HLA-DrlO/NEG 1110 monocyte: An immunosuppressive phenotype that restrains responses to cancer 1111 immunotherapy

Pathological inflammation in patients with COVID-19: a key 1113 role for monocytes and macrophages

Persisting low monocyte human leukocyte antigen-DR 1116 expression predicts mortality in septic shock

Different phenotypes of non-classical monocytes associated with systemic 1119 inflammation, endothelial alteration and hepatic compromise in patients with dengue

Heterogeneity of neutrophils

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity

Fatty acids and cancer-amplified ZDHHC19 promote STAT3 1128 activation through S-palmitoylation

A comprehensive single cell transcriptional landscape of 1131 human hematopoietic progenitors

Immunopathogenesis of coronavirus infections: 1133 Implications for SARS

Biological basis and pathological relevance 1135 of microvascular thrombosis

A subset of neutrophils in human systemic 1138 inflammation inhibits T cell responses through Mac-1

Decoding human fetal liver haematopoiesis

Single cell RNA sequencing of 13 human tissues 1143 identify cell types and receptors of human coronaviruses

Immunotherapies for COVID-19: 1146 lessons learned from sepsis

An immune-cell signature of bacterial 1149 sepsis

DNAM-1 and PVR regulate monocyte 1152 migration through endothelial junctions

Human polymorphonuclear neutrophils express RANK and are activated by its ligand, RANKL

Immunosuppression for hyperinflammation in 1157 COVID-19: a double-edged sword?

CyTOF workflow: Differential discovery in high-throughput high-1160 dimensional cytometry datasets

Modulation of immune crosstalk in COVID-19

Hepatic acute-phase proteins control innate immune 1165 responses during infection by promoting myeloid-derived suppressor cell function

Invariant NKT cells reduce the immunosuppressive 1169 activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans

Human neutrophils in the saga 1172 of cellular heterogeneity: insights and open questions

Emerging Principles in Myelopoiesis at 1174 Homeostasis and during Infection and Inflammation

Surface barcoding of live PBMC for multiplexed mass 1176 cytometry

Stabilizing Antibody Cocktails for Mass Cytometry

Neutrophil Diversity in 1180 Health and Disease

Neutrophil Activation during Septic Shock

SARS-CoV-2 entry factors are highly 1185 expressed in nasal epithelial cells together with innate immune genes

Human CD62Ldim neutrophils identified as 1188 a separate subset by proteome profiling and in vivo pulse-chase labeling

Interleukin-1191 3 receptor in acute leukemia

Leukocyte Protease Binding to Nucleic Acids Promotes Nuclear 1194 Localization and Cleavage of Nucleic Acid Binding Proteins

Early expansion of circulating granulocytic myeloid-derived 1197 suppressor cells predicts development of nosocomial infections in patients with sepsis

Myeloid-derived suppressor cells coming of 1200 age review-article

Kidney injury enhances renal G-CSF 1203 expression and modulates granulopoiesis and human neutrophil CD177 in vivo

Does comorbidity increase the risk of patients 1206 with covid-19: Evidence from meta-analysis

Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-1209 Infected Pneumonia in Wuhan, China

A single-cell atlas of the peripheral immune 1212 response to severe COVID-19

Virological assessment of hospitalized patients 1215 with COVID-2019

Characteristics of and Important Lessons from the 1217

COVID-19) Outbreak in China: Summary of a Report of 72314 1218 Cases from the Chinese Center for Disease Control and Prevention

A new coronavirus associated with human respiratory disease in China

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Increased formation of neutrophil extracellular traps is associated with gut leakage 1231 in patients with type 1 but not type 2 diabetes

Myeloid-derived suppressor cells: Their role in 1233 the pathophysiology of hematologic malignancies and potential as therapeutic targets

ClusterProfiler: An R package for comparing 1236 biological themes among gene clusters

Fatty Acid Synthase Promotes the Palmitoylation of 1238 Chikungunya Virus nsP1

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in 1241 Wuhan, China: a retrospective cohort study

A pneumonia outbreak associated with a new coronavirus of probable bat 1244 origin

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

SARS-CoV-2 Receptor ACE2 Is an Interferon-1250

Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets 1251 across Tissues

A dynamic immune response shapes COVID-19 progression

Neutrophil extracellular traps in COVID-19

We thank Michael Kraut and Heidi Theis for technical assistance. 1259 1260 1261 Deutsche COVID-19 Omics Initiative

Ulisses Nunes da Rocha

Max von Kleist, Andreas 1272 Walker

INST 37/1049-1, INST 216/981-1, INST 257/605-1, INST 269/768-1278 1 and INST 217/988-1, INST 217/577-1 to

); 1283 the EU projects ONE STUDY (grant number 260687 to B.S.), BIO-DrIM (305147 to B.S.) and 1284 INsTRuCT (grant number 860003 to B.S.), the German Federal Ministry of Education and 1285 Research (BMBF, project RAPID to

Software/data 1295 analysis

Writing -1298 Original Draft

1302 neutrophil subcluster, donor origin (blue = healthy controls, yellow = mild COVID-19, red = severe 1455 COVID-19) and expression intensity of CD34

Bar graphs summarizing CD34, CD62L, CD123 and PD-L1 expression as % positive cells 1458 within neutrophils of whole blood samples from COVID-19 patients with mild (n=5) or severe 1459 disease (n=5) course and age-matched healthy controls (n=7)

non-classical monocytes (D) CD34, CD62L, CD123 and PD-L1 expressing neutrophils (E) as well 1462 as CD11c and CXCR3 expressing classical monocytes (F) measured by mass cytometry in whole 1463 blood samples from cohort 1 distinguishing between COVID-19 patients with mild (days 0-10: 1464 n=3, days 11-25: n=10) or severe/critical disease